• Citer

The case for dosing dabigatran: How tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio

par Safouris, Apostolos ;Triantafyllou, Nikos;Parissis, John;Tsivgoulis, Georgios
Référence Therapeutic Advances in Neurological Disorders, 8, 6, page (245-254)
Publication Publié, 2015-11

Article révisé par les pairs

• Détails
• Contenu

Titre:	The case for dosing dabigatran: How tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio
Auteur:	Safouris, Apostolos; Triantafyllou, Nikos; Parissis, John; Tsivgoulis, Georgios
Informations sur la publication:	Therapeutic Advances in Neurological Disorders, 8, 6, page (245-254)
Statut de publication:	Publié, 2015-11
Sujet CREF:	Neurologie
	Pharmacologie
Mots-clés:	atrial fibrillation
	dabigatran
	dosing
Note générale:	SCOPUS: re.j
Langue:	Anglais
Identificateurs:	urn:issn:1756-2856
	info:doi/10.1177/1756285615601360
	info:scp/84945532654